Real-time monitoring of skin treatment

Through real-time monitoring systems and intelligent algorithms combined with multi-spectral reflection imaging and ultrafast dynamic scattering technology, the cosmetic laser treatment is automated, which solves the problem of relying on users' subjective judgment in the existing technology, and achieves a more efficient and safer cosmetic laser treatment effect.

CN118948433APending Publication Date: 2024-11-15LUMENIS BE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411047579.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-10-11
Filing Date
2019-10-07
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing cosmetic laser treatment technology is highly dependent on users' subjective judgment, resulting in uncertain treatment effects, low efficiency, high cost and adverse reactions, especially when operated by non-medical operators, the risk increases.

Method used

The real-time monitoring system is adopted to combine intelligent algorithms and robotic technology, and through multi-spectral reflection imaging and ultrafast dynamic scattering technology, skin characteristics are automatically diagnosed and laser parameters are adjusted in real time, so as to achieve automated and personalized control of the laser treatment process.

Benefits of technology

It improves the predictiveness and safety of treatment, reduces the incidence of adverse reactions, improves treatment efficiency and patient satisfaction, and reduces the dependence on professional physicians.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948433A_ABST
    Figure CN118948433A_ABST
Patent Text Reader

Abstract

A cosmetic method for treating skin tissue with a therapeutic light source, comprising: providing a therapeutic light source along an optical axis; providing one or more irradiation light sources along the optical axis; providing one or more sensors along the optical axis; a programmable controller is provided that controls activation of the irradiation light source and the treatment light source. The method includes the steps of: a controller activating and directing one or more illumination sources to skin tissue, one or more sensors measuring light reflected from the skin tissue and transmitting sensed information of the measured light to a programmable controller; the programmable controller processes the measured light received from the output of the one or more sensors and provides a therapeutic light scheme; the programmable controller activates the treatment light source according to the treatment scheme of the skin tissue; and treating skin tissue.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Case information

[0002] This application is a divisional application of the invention patent application with application number 201980067389.2 filed on October 7, 2019 and invention name “Real-time monitoring of the skin treatment process of cosmetic laser beauty”.

[0003] Related Applications

[0004] This application is related to U.S. Provisional Application No. 62 / 728,096 filed on September 7, 2018 and U.S. Provisional Application No. 62 / 744,219 filed on October 11, 2018, both of which are entitled “Real Time Monitoring of Laser Treatment Procedures”, the entire contents of which are incorporated herein by reference, and this application claims priority to U.S. Provisional Application No. 62 / 744,219 filed on October 11, 2018. This application is also related to U.S. Provisional Application No. 62 / 754,730 filed on November 11, 2018, entitled “Automation of Apparatus and Methods of Aesthetic Skin Treatments”, the entire contents of which are incorporated herein by reference. Background Art

[0005] To date, the laser-based aesthetic treatment paradigm has been largely completely manual and highly user-dependent, thereby relying heavily on the practitioner's subjective assessment of the subject's skin and target physical properties. However, implementation of technology elements that could transform the existing manual paradigm into an automated, more scientific, and user-independent model may be feasible. Such implementation has strong scientific plausibility given the principles of aesthetic medical laser treatment and the physical effects of laser-tissue interaction.

[0006] It is believed that in the cosmetic skin tissue treatment industry, companies have less experience with some of the key elements of adapting largely manual systems and methods to new technologies, namely, computer vision, image processing, artificial intelligence (AI) and robotics (including robotic operability, imaging and / or sensing elements).

[0007] A body of data, expertise, and experience already exists regarding creating and validating effective associations between certain target skin / lesion / hair properties and laser settings. For example, in the M22 laser system manufactured and sold by Lumenis, Inc. (the assignee of the present invention and application), this body of knowledge has been incorporated into certain "presets" for laser settings. Thus, an operator selecting certain presets initiates a treatment that may have been well developed based on years of experience providing treatment for a certain purpose by manipulating such things as the pulse width of the laser being provided, the power setting, the number of pulses, one or more wavelengths, and the like.

[0008] However, these presets are implemented under the control of the operator based on the operator's own subjective judgment of the person's skin type and the properties of the target lesion. Therefore, it is actually possible (although not currently personalized and automatic) to create an association between certain target properties and desired laser settings.

[0009] In generating the present invention, an analysis and conceptual design was undertaken to evaluate which technologies and methods could be combined with a medical laser platform to achieve automatic, on-board, real-time skin diagnosis and personalized calculation of laser settings that would eliminate reliance on subjective operator input and provide optimal clinical outcomes.

[0010] Additionally, such real-time systems have been developed that can be used in conjunction with a fully hands-free medical laser "robotic" platform for applications requiring high spatial accuracy (e.g., multiple small pigmented birthmarks or moles on the skin) and / or cumbersome coverage of larger surface areas (e.g., hair removal or tattoo removal).

[0011] It is envisioned that the next generation platform will likely include a therapeutic laser module, a new skin diagnostic module that uses intelligent algorithms to calculate the required laser settings, a new robotic module that will control and manipulate the laser applicator over the target area while taking into account safety and efficiency, and a new user interface that will allow the user to plan / mark the desired treatment area.

[0012] The technical feasibility of integrating robotic functions that allow for hands-free procedures has been partially proven, as robotics technology has been commercialized in various applications, including medical applications. There are several commercial products based on robotic functions in the health market. For example, Mazor Robotics has developed a robot-based system for the treatment of malfunctions in Da Such technology is provided in the surgical system.

[0013] Automated skin diagnosis and mapping of key chromophores has been demonstrated (e.g., using multispectral reflectance imaging, visual analysis) based on theoretical analysis and through a range of commercially available portable devices using similar principles (but each device is considered limited to a certain number of skin parameters, works offline, and is not integrated into a laser platform).

[0014] The technical feasibility of calculating the optimal laser settings based on, for example, diagnostic skin measurements of key chromophores has been partially proven, as the entire theory behind selective laser therapy has been extensively explored over the past 20 years using skin models that have been validated in clinical studies. In today's practice, the implementation of this knowledge is achieved through "presets" that are part of the system's user interface, although they rely entirely on the user's correct judgment and manual selection of the target properties.

[0015] The technical feasibility of seamlessly integrating skin diagnostic technology with a medical laser platform and closing the loop in real time to determine optimal laser settings using a smooth interface of process workflow has yet to be demonstrated and is a key design of the present invention.

[0016] Background and types of cosmetic treatments

[0017] Ultimately, while current cosmetic laser treatments do work, as mentioned, they are highly user dependent, often unpredictable, take a long time, are costly (e.g., due to the need for multiple diagnostic and office visits), and have varying complication rates. Typically, the practitioner visually inspects the subject's body area of ​​interest, and sometimes interviews the subject to learn about their typical skin reactions to sun exposure. Next, the practitioner can manually select laser parameters, either directly or through a "preset" user interface, and can then spray a test patch to analyze the skin's reaction to determine if the settings just made are acceptable.

[0018] The practitioner then proceeds with the treatment, covering the entire surface area by applying laser jets in a sometimes cumbersome stepwise fashion, which occasionally results in missed coverage or overlapping coverage, which sometimes results in under-treatment or over-treatment, respectively. If the laser settings are too weak, there may be under-treatment and repeated additional diagnostics (i.e., additional visits) may be required, increasing the overall burden and expense of treatment. If the laser settings are too strong, there may be over-treatment, resulting in undesirable adverse events such as temporary pain, varying degrees of blistering and burning, hypo- / hyper-pigmentation, scarring, and purpura (hemorrhage).

[0019] The rapidly growing cosmetic treatment market relies only on the experience of well-trained physicians (i.e., dermatologists). Physicians usually have knowledge about specific skin lesions (classification, composition and structure of the specific skin lesions). However, only some physicians have complete knowledge about the interaction between laser and tissue, which is crucial when setting the optimal laser parameters to achieve safe and effective clinical results. There is a growing market segment in the user market, and these users are practitioners with lower levels and lack the required knowledge (i.e., non-dermatologist MD, non-laser technicians, non-nurses or non-beauticians). In addition, treatment is usually manual and cumbersome. Practitioners can visually align the laser handpiece to the treatment position and manually transmit laser pulses. Practitioners may need to repeat the operation to cover the entire treatment area point by point or by sliding the handpiece in the case of continuous laser emission. This manual operation is cumbersome and difficult to control the quality of treatment in terms of coverage, overlap and repetition.

[0020] Much of the knowledge regarding the details of laser treatments (laser type, pulse duration, frequency, and fluence) is conveyed from laser manufacturers to practitioners through user manuals with general guidelines and software presets. The problems with these presets are: (1) they depend on the practitioner's subjective judgment of the target properties of the skin; (2) although these presets may have been tested on various skin types, the actual variety of skin types is much greater, so the proposed settings may not be optimal for the person / body area to be treated; (3) these presets do not take into account the actual physical characteristics of the tissue, such as the exact target diameter. Therefore, there is a clear need for a more robust approach to personalized skin analysis and tailored treatment plans.

[0021] Because the aesthetic market is so diverse in terms of the types of practitioners (ranging from professional dermatologists to aestheticians) and lacks clear quality assurance measures, it is difficult to clearly quantify how many treatments a patient could have avoided or how much clinical outcomes could have been improved if the practitioner had used optimal settings. Examples of treatment types are as follows.

[0022] Hair Removal

[0023] For hair removal, while one might expect that the typical number of hair removal treatments required to achieve satisfactory results would be in the range of around 6, in practice more treatments are often required. The reasons for this are not well documented and are multifactorial. However, based on experience, these reasons are associated with suboptimal adjustment of the laser parameters and / or suboptimal manual coverage of the surface area being treated. The former is a result of subjective assessment of the skin and hair type leading to suboptimal laser settings, while the latter is affected by the need to cover large surface areas (1000 cm x 400 cm) with a laser having a small spot size (up to approximately 3 cm x 3 cm) with difficulties controlling quality in terms of coverage, overlap and repetition. 2 Up to 2000cm 2 )’s impact.

[0024] Overlapping laser jets are likely to create additional problems. Not only is the overlapping laser jet inefficient in terms of time; it can also cause excessive pain (due to overheating) in the area of ​​overlapping treatment. Currently, hair removal is a cumbersome manual task, and it typically takes a 30-minute period to complete a treatment. In addition, the hair removal market has been expanded far beyond professional users to beauticians, for example, where beauticians can accurately determine the skin properties and hair properties, and therefore the appropriate laser settings may not be as good as those of professionals. This in turn will cause the subject to suffer significantly higher rates of dissatisfaction with the process and poor results. Another growing market is home devices for hair removal. In this market segment, users simply do not have the knowledge to select optimal parameters, and therefore for safety reasons, device manufacturers must compromise on efficacy. A technology that can scan the skin / hair and infer the optimal parameters that should be used for safe and satisfactory results may be very beneficial.

[0025] Tattoo Removal

[0026] In tattoo removal, the challenge is twofold. First, to selectively destroy tattoo inks, the optimal laser wavelength should be chosen to achieve selective absorption of one or more specific ink colors while minimizing nonspecific reactions. However, commonly used tattoo inks are barely regulated, and the composition of such inks varies widely. As a result, ink colors that appear similar may have a wide range of peak absorption, and practitioners are unable to determine the precise type / properties of a particular ink, and therefore the optimal laser wavelength that should be used.

[0027] Furthermore, in order to achieve optimal laser settings and clinical results, skin type (amount of melanin), ink depth and amount should be considered in addition to the color properties of the ink. Today, this entire process is done by practitioners based on their personal experience (or lack of experience!) and subjective assessment. Secondly, the tattoo surface area is often very large, as large as an entire hand, chest or back. In this case, the practitioner can use a spot size of about 1 cm 2 The laser handpiece manually treats areas up to 1200cm 2 of the surface area. The process is time-consuming and tedious. When it comes to tattoo removal, the average number of treatments reported is usually 6 to 10, but 15 to 20 or more treatments are not uncommon. The reasons may be multifaceted, but using suboptimal settings is certainly a key factor.

[0028] Blood vessel removal

[0029] To selectively destroy vascular lesions and veins, the practitioner may need to determine the depth and diameter of the target (and of course the skin type). Today, there is no other means except for subjective assessment of size and depth. Operators can use available portable irradiation devices that can highlight veins, but they will not provide quantification of any parameters important for effective laser treatment. The selection of laser parameters is complex. Wavelength (WL) selection is an important parameter that can determine tissue response. Ideally, the absorption ratio of vascular targets to normal surrounding skin should exceed 10:1. Since epidermal pigment covers the vessels, WL selection should be based on the optimal ratio of vascular destruction to pigment destruction. Pulse duration is another important parameter that limits the thermal response to the target vessel and is affected by the size of the vessel. With longer pulses (6ms to 40ms), thrombosis within the vessel and purpura of the spot size are reduced, because micro-heating can cause vascular wall stenosis and thrombosis of larger vessels rather than micro-vessels that produce extensive purpura. Spot size is also important and should be carefully considered with fluence, because larger spots may produce more epidermal damage and pain 6 .

[0030] Pigmented lesions

[0031] In order to selectively destroy pigmented lesions, the practitioner may need to determine the lesion type, skin type, melanin density of the lesion, and the depth of the lesion (e.g., whether it is epidermal, junctional, or dermal). Again, the entire process is done manually or by using available portable tools, and the entire process is completely dependent on the practitioner's knowledge and expertise to select the correct treatment. In order to effectively treat pigmented lesions, one should be familiar with the histopathological characteristics of the lesion.

[0032] With this knowledge, the lesion depth (i.e., epidermis, dermis, or a combination of both) can be determined, and the most appropriate laser settings can then be decided. A sample rule for laser selection is as follows: a benign pigmented lesion located on a shallow surface may be treated with a shorter wavelength (e.g., 532 nm), but a deeper lesion may well require a longer wavelength (such as, 1064 nm) to achieve better deep penetration. A larger spot size will also enhance penetration depth. Pigmented lesions with atypical features (e.g., asymmetry, borders, color) are examples of lesions that may not be treated with lasers. Unfortunately, pigmented lesions vary in their response to lasers, and it is difficult to predict treatment outcomes for any individual. The reasons are undoubtedly multifaceted, but subjective laser selection certainly may play an important role in them.

[0033] Adverse reactions (safety)

[0034] The following data describe common adverse events (AEs) associated with current manual cosmetic laser treatments: In a meta-analysis (Shen L, Zhou G, Zhao J, Li P, Xu Q, Dong Y, Zhang Z. Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis. QJM. 2015 Jun;108(6):473-80) and large-scale reviews, the overall incidence of adverse events (AEs) in venous (hemangioma) treatment was 6.3%. In another pigmentation (melasma) study (Halachmi S, Haedersdal M, Lapidoth M. Melasma and laser treatment: an evidenced-based analysis. Lasers Med Sci. 2014 Mar;29(2):589-98), AE worsening was up to 13.3%, pigmentation up to 17%, blistering up to 6%, and crusting up to 4%.

[0035] Based on database-reported cases between 1994 and 2013, FDA MAUDE Data on Complications with Lasers, Light Sources, and Energy-Based Devices (FDA MAUDE Data on Complications with Lasers, Light Sources, and Energy-Based Devices; Anne Marie Tremaine, MD, and Mathew M. Avram, MD; Lasers in Surgery and Medicine 47:133–140 (2015)) reported more than 1200 medical device reports (MDRs) (e.g., 690 burns and blistering, 155 scarring, and 147 heterochromia). The authors concluded that laser hair removal was the most common indication associated with AEs, and the most common AEs seen across all devices were blistering and burning, followed by scarring, heterochromia, and skin atrophy.

[0036] In most cases, after investigation, AEs determined by the manufacturer were likely due to operator error (including improper settings). In reality, because many physicians may never report AEs to the FDA, the actual number is likely much higher. It is likely that non-physician operators experience higher rates of AEs during cosmetic procedures than physician operators:

[0037] Most importantly, there is a clear trend showing a dramatic increase in the number of lawsuits associated with laser surgery performed by nonphysician operators (NPOs). NPOs include a wide variety of operators, including nurse practitioners, registered nurses, medical assistants, and estheticians, among others. One study (Jalian HR, Jalian CA, Avram MM, Increased risk of litigation associated with laser surgery by nonphysician operators, JAMA Dermatol. 2014 Apr;150(4):407-11) tracked 175 legal cases involving injuries from skin laser surgery from 1999 to 2012. During that time period, 75 cases (43%) involved nonphysician operators of the laser, an increase from 36% in 2008 to 78% in 2012. Summary of the invention

[0038] In one aspect, a cosmetic method for treating skin tissue using a therapeutic light source includes providing a therapeutic light source along an optical axis; providing one or more illumination light sources along the optical axis; providing one or more sensors along the optical axis; and providing a programmable controller, the programmable controller controlling the activation of the illumination light source and the therapeutic light source. The method includes the following steps: the controller activates the one or more illumination light sources and directs them to the skin tissue, the illumination light is reflected from the skin tissue along the optical axis to the input end of the one or more sensors; the one or more sensors measure the light reflected from the skin tissue and transmit the sensed information of the measured light from the output end of the one or more sensors to the programmable controller; the programmable controller processes the measured light received from the output end of the one or more sensors and provides a therapeutic light regimen; the programmable controller activates the therapeutic light source according to the treatment regimen for the skin tissue; and treats the skin tissue.

[0039] In another aspect, the method may further include providing a light directing element to direct both the therapeutic light source and the illumination light source along the optical axis.

[0040] On the other hand, the irradiation light source can be a plurality of light sources with different light output wavelengths; the method further comprises the following steps: the controller selects one or more light source wavelengths from the plurality of different light source wavelengths and activates the one or more light sources to irradiate the skin tissue. The plurality of light sources are LED light sources. Further, the wavelength of the LED light source is in the range of 400nm to 900nm. Still further, the therapeutic light source is selected from one or more of the following: a fiber laser source, a solid-state laser source, an intense pulsed light (IPL) light source, and an LED light source. The skin tissue is treated for one or more of the following categories: pigmented lesions, blood vessel removal, tattoo removal, and hair removal.

[0041] In yet another aspect, the method may further include the step of the controller selectively activating one or more of the one or more LED light sources according to the skin tissue treatment category. Further, activating one of the one or more illumination light sources may depend on the depth within the skin tissue. The method may further include the step of: after the step of treating the skin tissue, reactivating the one or more illumination light sources to determine the condition of the skin tissue after treatment.

[0042] In yet another aspect, the step of the programmable controller processing the measured light received from the output of the one or more sensors and providing a therapeutic light regimen includes the steps of analyzing the information by matching the information with information in a lookup table contained in a memory associated with the programmable controller; and selecting a therapeutic regimen based on the matches in the lookup table. In addition, the step of the programmable controller processing the measured light received from the output of the one or more sensors and providing a therapeutic light regimen includes the steps of analyzing the information by matching the information with information contained in one or more embedded algorithms contained in a memory associated with the programmable controller; and selecting a therapeutic regimen based on the matches. Further, the step of the programmable controller processing the measured light received from the output of the one or more sensors and providing a therapeutic light regimen includes the steps of analyzing the information by matching the information with information contained in a memory associated with the programmable controller using artificial intelligence methods and deep learning; and selecting a therapeutic regimen based on the matches.

[0043] On the one hand, a device for treating skin tissue using a therapeutic light source, the device comprising: a therapeutic light source along an optical axis; one or more illumination light sources and a sensor along the optical axis; a programmable controller, the programmable controller controlling the activation of the illumination light source and the therapeutic light source; the device further comprising: the controller being configured to activate the one or more illumination light sources and direct them toward the skin tissue, the illumination light being reflected from the skin tissue along the optical axis to the input end of the one or more sensors; wherein the one or more sensors measure the light reflected from the skin tissue and transmit the sensed information of the measured light from the output end of the one or more sensors to the programmable controller; the programmable controller being further configured to process the measured light received from the output end of the one or more sensors and provide a therapeutic light plan; the programmable controller being configured to activate the therapeutic light source to treat the skin tissue according to the treatment plan for the skin tissue.

[0044] In another aspect, the device further comprises a light directing element for directing both the treatment light source and the illumination light source along the optical axis. The illumination light source comprises a plurality of light sources having different light output wavelengths; and wherein the controller is configured to select one or more light source wavelengths from the plurality of different light source wavelengths and activate the one or more light sources to illuminate the skin tissue. Further, the plurality of light sources are LED light sources; and the wavelength of the LED light source is in the range of 400nm to 900nm.

[0045] In another aspect, the therapeutic light source is selected from one or more of the following: a fiber laser source, a solid-state laser source, an intense pulsed light (IPL) source, and an LED light source. Further, the skin tissue is treated for one or more of the following categories: pigmented lesions, blood vessel removal, tattoo removal, and hair removal.

[0046] In one aspect, the controller can be configured to selectively activate one or more of the one or more LED light sources based on the skin tissue treatment category. Further, the controller can be configured to activate one of the one or more illumination light sources based on the depth within the skin tissue. The controller can be configured to reactivate the one or more illumination light sources after treating the skin tissue to determine the condition of the skin tissue after treatment.

[0047] On the other hand, the programmable controller processes the measured light received from the output end of the one or more sensors and provides a therapeutic light plan including the following steps: analyzing the information by matching the information with information in a lookup table contained in a memory associated with the programmable controller; and selecting a therapeutic plan based on the matching items in the lookup table.

[0048] On the other hand, the programmable controller is configured to process the measured light received from the output end of the one or more sensors and provide a therapeutic light regimen including: the controller is configured to analyze the information by matching the information with information contained in one or more embedded algorithms, the one or more embedded algorithms being contained in a memory associated with the programmable controller; and then the controller is configured to select a therapeutic regimen based on the matching items.

[0049] On the other hand, the programmable controller is configured to process the measured light received from the output end of the one or more sensors and provide a therapeutic light plan, including: the controller is configured to analyze the information by matching the information with information contained in a memory associated with the programmable controller using artificial intelligence methods and deep learning; and then the controller is configured to select a treatment plan based on the match. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 A high-level functional architectural scheme of the present invention is presented.

[0051] Figure 2 A conceptual illustration showing a hands-free automated laser medical treatment device.

[0052] Figure 3 Presented are the current treatment problems and the proposed solutions in this invention.

[0053] Figure 4 The conceptual differences between ultrafast dynamic scattering and multispectral reflectance imaging are demonstrated.

[0054] Figure 5 Typical histological layers of human skin tissue are shown.

[0055] Figure 6 A schematic representation of light reflections from various layers of human skin tissue is shown.

[0056] Figure 7 Plots showing reflectance as a function of light wavelength for different skin colors and blood types.

[0057] Figure 8 A schematic high-level block diagram of data acquisition and processing within the present invention is presented.

[0058] 9A to 9H Schematic diagrams of various handpieces embodying aspects of the present invention are shown.

[0059] Fig.10 A sequence of events pertaining to various aspects of the invention is presented.

[0060] Fig.11 Demonstrates the scattering properties of light incident on skin tissue.

[0061] Fig.12 The angular distribution of the scattering characteristics of Mie scattering and Rayleigh scattering is shown.

[0062] Fig.13 An image of a display on a GUI or other device during the process is shown.

[0063] Fig.14 Spectra of different chromophores are shown.

[0064] Fig.15 An embodiment of a skin monitoring device is presented.

[0065] Fig.16 Results of determining information from skin tissue using spatial frequency domain segmentation are presented.

[0066] Fig.17 One embodiment of the structure of an ommatidium for use with the present invention is shown.

[0067] Fig.18 A semidome structure is shown with ommatidia implanted in the shell of the structure.

[0068] Fig.19 Shows something like Fig.18Another semi-dome structure of the present invention, but in which an additional wide-angle sensor is mounted on the inner surface of the structure.

[0069] Fig. 20 The dome structure with a treatment laser port, an irradiation port, a fiber optic port for a fast optoelectronic sensor, and an ommatidium port is shown.

[0070] Fig.21 Another embodiment of a half dome structure with mounted sensors is shown. DETAILED DESCRIPTION

[0071] Based on the above discussion, the present invention aims to provide a system and method for real-time monitoring of laser treatment processes, thus paving the way for automation efforts towards aesthetic medical laser platforms. The desired goal is to expand currently available commercial products into a complete end-to-end solution including automatic setting of laser parameters.

[0072] The ultimate desired solution is a hands-free automated platform that will enable planning and automated execution of treatments, with the system continually self-determining the appropriate laser settings in real time and then moving at each specific anatomical target.

[0073] In such a system, the practitioner can simply provide the clinical diagnosis and purpose, one or more desired treatment areas, "no-spray" zones, and similar parameters via a designated GUI. The system can be designed to determine laser parameters before each laser spray and monitor the treatment process online, thereby providing closed-loop feedback to the laser system to adjust treatment parameters as needed to achieve the optimal clinical result. Possible target aesthetic markets for such a system are vascular and pigmented lesion treatment, hair removal, and tattoo removal.

[0074] The present invention may be incorporated into an image-guided autonomous robotic system, such as the system described in U.S. Provisional Application No. 62 / 754,730, filed on November 2, 2018, the entire contents of which are incorporated herein.

[0075] As in Figure 2 As can be seen in FIG. 1 , the proposed system may include a console / control unit 10 , a user interface 12 , a motion unit 14 , a laser and skin analysis system 16 , and an imaging and sensing module 18 .

[0076] The console / console unit 10 may be installed in the form of a portable laser console which will preferably be compact, low weight, low cost and low power consumption in order to conform to existing clinic infrastructure, workflow and economic models.

[0077] The system can use an imaging / sensing subsystem to capture the treatment area on the patient and track the motion in real time. Based on the data obtained, the system can be able to identify treatment regions of interest (ROIs) and subdivide these treatment regions of interest into treatment points. The system can then use a motion unit to guide the laser beam to the treatment area, and then scan the treatment area using a laser beam perpendicular to the scanned patient surface. The laser can have a collimated and long focal length beam with a variable spot size to eliminate the need to closely track the curvature of the human body and by doing so enable faster and simpler operation of the motion system.

[0078] In addition to macro-level planning, execution, and control, the system also enables real-time skin diagnosis and monitoring at the treatment target location, and continuously adjusts laser parameters using embedded algorithms and artificial intelligence methods.

[0079] As discussed in incorporated 62 / 764,730 filed November 2, 2018, at a high level, the technology can be based on a fast multispectral reflectance / scatter imaging device integrated within a therapeutic laser handpiece and platform.

[0080] The reflected image from skin tissue is determined by two physical properties (chromophore absorption and reduced induced irradiation scattering). Integrating those parameters through tissue depth produces the reflected image. Thus, reflectance imaging (different wavelengths, polarizations and patterns) provides information about fundamental skin optical properties at depths up to several millimeters.

[0081] This configuration may well allow monitoring of tissue conditions before, during and after treatment and determination of optimal laser settings in real time.The therapeutic laser jet time period is short and therefore it is desirable that the sensing and decision making system will also be fast, ie able to deliver feedback signals in less than a few milliseconds.

[0082] Therefore, the present invention is designed to provide seamless integration of automation and imaging technologies with a cosmetic medical laser system that uses advanced computational methods and algorithms to free cosmetic treatments from guesswork and manual operations. Instead of relying too much on the experience (or lack thereof) of trained physicians, their subjective assessments, personal preferences, and tedious work, the present invention can provide a hands-free system that automatically plans and treats the entire surface area based on scientific quantification of target properties and intelligent calculation of optimal laser settings. This innovative technology may have the following possibilities: improve clinical outcomes; achieve satisfactory results in less time and require fewer office visits; reduce AE rates, especially when the system is operated by less skilled operators; improve economic models, and ultimately increase patient satisfaction.

[0083] Technology of the present invention

[0084] Figures 1 to 3 The high-level system functional architecture of the technology to be implemented, a conceptual illustration of a hands-free automated laser treatment system, and an illustration of current paradigm deficiencies in current treatment options and the proposed solution are presented, respectively.

[0085] The envisioned automated medical laser platform may include the following technologies within the modules discussed below:

[0086] 1. Skin diagnosis

[0087] 1.1 Dynamic multispectral reflectance imaging (e.g., CMOS-based)

[0088] 1.2 Real-time monitoring of laser therapy using photodiode-based ultrafast dynamic scattering

[0089] 1. Skin diagnosis

[0090] This article describes two different approaches to skin diagnostics, image sensor-based multispectral reflectance imaging and photodiode array-based ultrafast dynamic scattering. While both rely on the collection of light reflected from the tissue surface, they have different properties, development risks, and potential advantages and disadvantages associated with a range of potential products and applications. Figure 4 The conceptual difference is shown in .

[0091] Although reflectance imaging technology ( Figure 4 ) uses a camera to collect light signals with relatively narrow angular divergence from its field of view (FOV), but with dynamic scattering ( Figure 4 ) provide almost hemispherical stereo angle collection from a relatively small area. While the former can give good spatial information about the target area, the latter is more sensitive to treatment-induced changes. In addition, the sampling rate and dynamic range of a single pixel (photodiode) detector are much higher than those of an imaging device, allowing tracking of subtle changes in scattering at GHz rates. On the other hand, Figure 4 The imaging devices shown in , although these imaging devices may be inferior, can provide a certain degree of flexibility and reduce their resolution to increase the sampling rate. Since personalization and optimization of laser treatment parameters will require both spatial and dynamic information, the feasibility of both technologies may be considered.

[0092] 1.1 Dynamic multispectral reflectance imaging based on image sensor

[0093] Skin tissue is a very complex biological organ. Although the basic structure is the same for all people (see Figure 5), but there is much variation within different regions of a given individual and between individuals. Such variations include skin color (melanin content in the basal layer), hair color and thickness, collagen integrity, vascular structure, various types of vascular lesions and pigmented lesions, foreign objects such as tattoos, etc.

[0094] Integration of wavelength-dependent scattering by tissue layer structures ( Figure 6 ) determined the reflectance patterns that can be adopted for various induced illuminations. Thus, reflectance imaging (different wavelengths, polarizations and patterns) provides information about fundamental skin optical and physical properties up to a depth of several millimeters. Figure 7 An example of how the total diffuse reflectance spectrum of a specific skin region with different levels of melanin, epidermal and dermal thickness, and blood content varies with respect to different wavelengths of light is shown. The circles on the graph represent the Fig.9F The same wavelengths used in the embodiments are 460nm, 520nm, 590nm, 611nm, 660nm and 850nm.

[0095] In this application, a non-contact integrated therapeutic and imaging laser applicator will be described. The non-contact integrated therapeutic and imaging laser applicator is designed to irradiate the treatment area with a series of different wavelengths, polarizations and spatial patterns, and then collect a series of reflection images before and immediately after the treatment. Using image processing, principal component analysis (PCA), physical modeling and finally neural network algorithms, the acquired reflection imaging data can be processed and laser treatment parameters can be set. At a high level, this will be carried out in three main stages: preclinical and clinical data collection stage, algorithm training stage for classification and treatment prediction stage, and algorithm confirmation stage.

[0096] like Figure 8 Schematically shown, during the data collection phase, spectral images can be dynamically acquired in real time during laser treatment. Pre-treatment multispectral images (A) are followed by application of laser treatment pulses (Tx), which can vary from nanosecond durations for tattoo and pigmented lesion removal treatments to tens of milliseconds for hair removal and vascular treatment. During application of the treatment laser, the irradiation and imaging systems can be protected by providing a shutter. The treatment laser penetrates the skin tissue, is absorbed by the chromophores and causes a series of reactions (including photochemical, thermal, acoustic and physiological). These reactions produce the desired treatment results, such as soft tissue coagulation, mechanical decomposition of tattoo pigments followed by scab formation, photothermolysis or vein collapse. These immediate results affect the absorption and scattering properties of the tissue, and thereby change the wavelength-dependent reflectance image. As long as the target remains in the FOV of the imaging system, those dynamic changes can be tracked (B).

[0097] The raw reflections before treatment and the reflections immediately after treatment can be processed using principal component analysis (PCA), which will enable robust classification of valuable parameters while reducing the overall dimensionality of the acquired data. In other words, PCA distinguishes data features according to their importance to the final clinical outcome (C). The most relevant parameters can be used to develop physical laser-tissue interaction models, including, for example, thermal relaxation and soft tissue coagulation. In addition, a large amount of highly correlated (A-Tx-BC) data allows the construction of empirical equations based on quantified immediate biological responses, such as erythema during hair removal and frosting formation during tattoo removal treatments. Currently, immediate responses are subjectively assessed in a non-quantitative manner by trained physicians without any dynamic quantification. In addition to commercial benefits, the platform envisioned by the present invention is a novel and robust research tool for clinical biophysics.

[0098] For most clinical indications, user guidelines for laser treatment parameters, typically provided by the manufacturer, are first determined by various physical models and then validated by clinical experiments. Thus, light-tissue interaction models are valuable tools for overall clinical outcome prediction. Rules of thumb suggest that physical models can achieve 80% correct predictability in real-life complex systems. The most effective way to improve the correctness of treatment parameters to achieve the desired results may be to use artificial intelligence techniques such as deep learning (DP). Deep learning involves the use of complex multi-level "deep" neural networks to create systems that can perform feature detection based on large amounts of unlabeled training data and can easily outperform old-fashioned physical reasoning methods. Trying to incorporate all parameters and their sometimes multi-factorial and weak correlations into a physical model is cumbersome, often impossible, and most importantly, can result in unstable solutions.

[0099] In the long term, after clinical data will be collected, analyzed and correlated with pre-treatment spectral reflectance imaging data and short-term post-treatment immediate spectral reflectance imaging data, a production version can be implemented in various laser treatment platforms. The production-level system specifications will be as relaxed as possible (depending on the results of the research plan and user requirements). For example, the production-level system specifications may use pre-treatment images (A) ( Figure 8 ), and then decides on the optimal treatment parameters based on a large previously collected database. The production-level system manual can also use non-dynamic post-treatment images (B) to provide initial feedback and evaluate the effectiveness of the treatment based on a previously relevant clinical outcome database (C).

[0100] exist Fig. 9AA potential imaging therapy laser applicator is shown in . The imaging therapy laser applicator integrates three main components that share the same output optics: a treatment laser section, an irradiation section, and an image acquisition section. The requirements for the laser will vary with the clinical indication and affect the coupling to the applicator. Depending on the treatment, an articulated arm system, a laser handpiece with a collimator, or a high-power optical fiber can be attached to the back of a variable zoom system. The purpose of the zoom system is to deliver the collimated therapeutic laser to the desired target area on the target skin surface.

[0101] Fig. 9A It includes: Part A, i.e., an imaging part including zoom optics (L) and polarization optics (P) and a CMOS or other sensor (S). Further, a treatment laser part B includes a high-power laser fiber (F1), a zoom optics (L) and a folding mirror (FM). An irradiation light part C includes an irradiation fiber (F2), a zoom optics (L) and polarization optics (P) and a Fourier space filter (M). This is only an exemplary embodiment, and many other variations can be implemented.

[0102] Within this portion of the applicator, multiple (perhaps motorized) folding mirrors may be mounted to switch between the irradiation imaging component and the treatment component. Adjacent to the treatment component is the irradiation component portion C. The purpose of this irradiation component portion is to irradiate the target area through a series of wavelengths, polarizations, and spatial patterns. The irradiation component portion may include a light delivery fiber system with collimating optics, a polarizer, a variable special filter in the Fourier plane of the irradiation system, and a folding mirror for enabling light to propagate through the same path as the treatment laser. The wavelength of the irradiation system can be controlled by applying appropriate filters before entering the irradiation fiber. Finally, the third component of the applicator is an image acquisition and recording device A. The image acquisition and recording device may include a CMOS / CCD sensor, a polarizer, a variable wavelength filter, a variable zoom optics, and a folding mirror that guides light reflected from the skin surface through the central applicator optics to the sensor.

[0103] In order to achieve the above Fig. 9A For the treatment devices described, adapters can be developed for existing vendor products. For example, currently, for the assignee of the present invention, Lumenis Ltd., there are two handpieces on the market, the first being the M22 Multi-spot Nd:YAG for vein, vascular lesion and hair removal, and the second being the Q-switched Nd:YAG handpiece for tattoo and pigmented lesion removal. Both handpieces have the same form factor and can be integrated into an imaging adapter as part of the treatment laser (e.g. Fig. 9B shown).

[0104] FIG. 9C to FIG. 9G Adaptation of the invention to other light therapy devices is demonstrated.

[0105] For example, Fig. 9C Another embodiment suitable for a fiber coupled laser source is shown. In this embodiment, the applicator 301 is connected to a fiber laser source (not shown) of known type at 302. As shown, the laser beam axis path 303 from the fiber laser source is shown within the applicator 301, passing through the applicator and out of the skin tip adapter 314. The laser fiber optical axis 303 first travels through suitable laser collimation optical elements 304, and then through laser focusing optics 310. Next is a dichroic reflector 311 in the downstream of the optical axis 303. The laser beam then passes through an illumination ring 312 (hereinafter combined with Fig.9F Detailed description will be given below) and then passes through the polarized optical ring 313. The calibration ring 315 is mounted at the distal end of the skin tip adapter 314.

[0106] The illumination light source may be placed in line with the optical axis 303 to illuminate the skin tissue. When the illumination light source 312 is activated by a suitable programmable controller that may be included in the console 10, the light reflected from the skin tissue will be reflected back through the adapter 314, the rings 312 and 313, and then incident on the reflector 311. The reflector 311 deflects the reflected light to another reflector 309, thereby reaching the polarization optical device 307, the focusing optical device 306, and then reaching the CMOS / CCD sensor 305 along the imaging beam axis path 308. The sensor 305 measures the light it receives and analyzes the light according to the present invention, and then may cause the modification of the output of the fiber laser source, all of which are performed in suitable electronic devices and programmed in the programmable controller. Although the annular illumination light source 312 is shown and will be described below, it should be understood that other suitable light sources can be provided instead of the ring 312 or in addition to the ring.

[0107] Now go to Fig.9D , which shows another combined laser / imaging device 501. Here, in addition to the fiber laser input source, a laser module is included within the applicator, which may be a solid-state laser source 502 of a known type. Otherwise, the optical path and optical elements 503 to 515 correspond directly to Fig. 9C Such elements in the embodiments of the present invention.

[0108] and Fig. 9C The same implementation scheme as Fig.9DThe embodiment also includes a polarizing optical ring 513 and an illumination ring 512, the structures and functions of which will now be discussed. The polarizing optical ring 513 is provided to cross-polarize each image received from reflections from skin tissue.

[0109] Now go to Figure 9G , which shows yet another embodiment of the present invention, in this case a fractional laser 700. Figure 9G The components within the device Fig. 9C and Fig.9D The elements in FIG. 7 are almost identical to those in FIG. 7 , except that one or more known scanning mirrors 704 are added to direct the laser energy to discrete, separate points on the skin tissue (e.g., Figure 9H ), where the display 800 on the GUI 816 will use the image from the CMOS / CCD sensor described above to display the live skin image 817 and the treatment point 818.

[0110] Go to Fig.9F , which shows the illumination ring 512 in detail. Here, the ring can be a disk-shaped holder 600 with an opening 607 that allows the laser beam and reflected light to pass through it. A plurality of LEDs 601 to 606 are shown mounted around the perimeter of the ring 600. Although the figure shows only a certain number of LEDs, it should be understood that any suitable number of LEDs (or other light sources) with different wavelengths can be mounted on the ring 600.

[0111] By way of example only, the LEDs may have wavelengths typically in the range of 450 nm to 900 nm: 460 nm (601), 520 nm (602), 590 nm (603), 611 nm (604), 660 nm (605), and 850 nm (606). As mentioned, these wavelengths are exemplary only, and other wavelengths may be used. The primary purpose is to provide a broad spectrum of illumination applied to the skin, from blue to red to the IR range, so that the reflectance can be measured using the sensor 305 or 505 described above. It is known that different wavelengths incident on skin tissue will have different penetration depths and different reflections / scattering. For example, while blue light may provide data about skin pigmentation at one end of the spectrum, red light may provide data at the vascular level and even deeper into the skin. By selecting and activating one or more of the LEDs, information / data about the skin condition may be sensed by the onboard sensors (e.g., sensors 305 and 505). The data received by the sensors may be transmitted to the console 10 via a suitable cable or wirelessly, and may be displayed on the user interface 12. A programmable controller within the console 10 can read one or more outputs of the sensor 505 at one or more wavelengths, and then process these outputs through a suitable processor or computer unit to determine which settings of the laser unit 16 to apply to the tissue. The programmable controller can have a memory containing a lookup table that matches, for example, reflectance measurements to certain skin conditions, taking into account skin type, and controls the application of laser treatment or provides suggested treatment parameters or treatment regimens to the operator of the device. In addition, when such a device is used and readings from multiple patients are sensed and recorded, AI techniques can be used to further refine the treatment parameters and treatment regimens.

[0112] Now go to Fig.9E , which shows the application of the invention to an applicator for generating intense pulsed light (IPL). IPL sources are known per se in the art, but here the IPL source is modified in structure and operation.

[0113] The IPL applicator 401 includes an IPL lamp 403 and an IPL filter 402. Since the IPL lamp 403 is an incoherent light source, the filter 402 is inserted between the lamp and the skin tissue to filter out unwanted wavelengths of light in a known manner. The applicator may include a light guide 407 that can be placed in contact with the patient's skin tissue. The light guide can be glass, sapphire or other (usually) transparent material. Light from the lamp 403 passes through the filter 402 and thereby reaches and passes through the light guide 407. The filter 402 can be of a removable, replaceable type so that, as with the light ring 600 discussed above, the target tissue can be incident with light of different wavelengths.

[0114] Typically, the light guide used in an IPL device may be rectangular, but is modified here to include an illumination coupling optic 408, a polarization optic 409, an illumination plate 410, and a calibration edge 411. Elements 408 to 410 are used to illuminate the patient's skin tissue before, during, and / or after treatment with an IPL light source, as described above with reference to Fig. 9C and Fig.9D The irradiation systems described are very similar.

[0115] Further, as in Fig.9E As seen in the upper left corner of FIG. 4 , light guide 407 is further modified to include elements 404, 405, and 406. These elements are CMOS / CCD sensor 404, image focusing optics 405, and polarization optics 406. As with the previous embodiments, light irradiating the skin via illumination plate 410 is transmitted through light guide 407 to sensor 404 and used to potentially modify the operation of the IPL light source as described above.

[0116] 1.2 Ultrafast dynamic scattering for real-time monitoring based on photodiode arrays

[0117] The aim here is to provide a tool for online monitoring of the treatment process and providing feedback to the laser system in order to adjust the treatment parameters and obtain effective treatment and safely reach the desired endpoint.

[0118] Monitoring tissue conditions before, during, and after treatment provides the clinician and laser system with the information needed to decide how to proceed. It is particularly advantageous to close the system loop and control individual treatment parameters during the procedure. Since treatment cycles are short in many cases, fast sensing and decision systems that can deliver feedback signals within milliseconds are preferred. Fig.10 A conceptual block diagram is presented in .

[0119] like Fig.10 As shown, the process of utilizing system 130 includes the following steps: determining initial laser system settings; applying treatment 134 to tissue 136 using those settings; monitoring / inspecting / sensing the treated tissue 138; and based on that monitoring / inspecting / sensing, changing treatment parameters 142 in a real-time loop 140 (when and if needed or appropriate).

[0120] The proposed concept is based on the monitoring of optical tissue properties which tell something about the tissue condition, e.g. normal tissue, coagulated tissue, melanin content. Two optical properties that can be considered can be absorption and scattering. The adopted technique is to first irradiate the target tissue and then measure the reflected light. Depending on the temperature and treatment time, when the tissue is treated and transformed into a new state, the internal structure of the tissue is modified and its absorption and scattering properties also change (see Fig.11). Since there is a strong correlation between the scattering pattern and the skin condition, information about the condition can be inferred by monitoring the spatial distribution of the scattered light. In order to be able to use this information to apply real-time feedback to the laser system, the data acquisition and analysis can preferably provide this information in around 1 ms.

[0121] When monitoring a solidification process, for example, the plan might be to monitor the angular distribution of the scattering as it moves from a Mie scattering pattern to a Rayleigh scattering pattern. Fig.12 It can be seen that for scattering of similar size or larger than the wavelength (Mie scattering), most of the scattering is forward, while for scattering smaller than the wavelength (as in the case of coagulated tissue), there is a transition to the Rayleigh regime and the radiation is scattered in all directions. For other processes (such as treating pigmented lesions), the light absorption in the treatment area can be monitored by monitoring the intensity of the reflected light.

[0122] Fig.13 901 on the console just before, during, and after a treatment process. As discussed above, a live skin image 902 of the treatment area may be displayed on the GUI 901 prior to activating the treatment laser device. By changing the above and herein discussed Fig.9F The wavelength of the light source can detect and display the depth of each tissue. Fig.13 In the embodiment of FIG. 1 , the superficial vein 904 and the deeper "blood feeding" vein 203 can be displayed at 905. The operator of the device can then decide which type of treatment is desired and activate the laser device which can provide treatment based on the protocol stored in the device. However, using the present invention as described herein, the device can be programmed to image skin tissue (e.g., Fig.13 ) and then based on these images more or less autonomously activates a treatment protocol for the patient's skin tissue.

[0123] Fig.14 The characteristic spectral scattering of skin tissue and the absorption coefficients of selected chromophores are presented in .

[0124] One embodiment of the monitoring device can be implemented by using a semi-dome structure (such as Fig.15 This can be accomplished by using a fast photodiode array arranged in a 3D image (as shown). By using different wavelengths to monitor different depths and different aspects of tissue condition, more information can be obtained to enhance the decision algorithm. In this way, the spatial distribution of scattered light can be monitored, tissue condition can be assessed, and the preferred laser settings can be inferred.

[0125] Several simultaneous detection channels can satisfy multiple applications. For example, a target channel and a reference channel can be used to monitor the course of a treatment and introduce optical endpoints to a unique and personal level. In another application (real-time spatial frequency domain segmentation), light sources that generate different spot sizes or different spatial patterns can be used. As the spatial frequency decreases (spot size increases), the light penetration depth increases and information from deeper levels in the tissue can be obtained. Therefore, by subtracting the data obtained from multiple accumulated depths, information from a specific layer inside the tissue can be obtained.

[0126] As shown in the cross-sectional view of skin tissue 190 Fig.16 As can be seen, one type of targeted illumination using one spatial modulation can generate information of the skin from one depth 192, while using another spatial modulation can reveal information at a deeper depth 196. By measuring the scattering and intensity of the two data sets, lock-in detection with two different frequencies can be used for each of the two data sets. The data difference can be used to extract real-time information specific to layer 194 between layer 192 and layer 196. If desired, additional illumination patterns can be generated to discern additional skin tissue layers.

[0127] Another implementation using multi-channel irradiation is for spectral real-time monitoring. By doing so, more data is added to the feedback function to make the decision more accurate. This is especially important when trying to determine safety endpoints. This applies not only to laser treatments based on thermal processes such as coagulation, but also in photoacoustic based treatments such as tattoo removal, where repeated irradiations on the same or adjacent points are common. With intelligent real-time data analysis, skin conditions can be monitored with the additional capability of stopping treatment if changes that could lead to adverse events are detected.

[0128] Yet another implementation of this technology could be to create a real-time spectral image of the focal treatment area using this technology. This could be done by mimicking the concept of compound eyes possessed by insects. Compound eyes (see Fig.17 ) consist of thousands of ommatidia, which are tiny, individual light-sensing units that include a cornea, a lens, and photoreceptor cells that distinguish brightness and color. Essentially, the image perceived by, for example, an insect is a combination of inputs from numerous ommatidia, which are oriented to point in slightly different directions. Compared to monocular eyes, compound eyes have poor image resolution; however, they have a very large viewing angle and the ability to detect fast movement (and, in some cases, polarization of light).

[0129] By embedding the sensor 212 in Fig.18By ensuring that different "ommatidia" have different FOVs and that they cover the entire ROI together, an image of the ROI can be obtained. Since the sensor is fast and simultaneous spectral signal picking (depending on the illumination) can be performed, a fast spectral imaging device can be obtained. In order to make the assembly easier and more dense, a fiber-coupled sensor can be used, so there is only a fiber port on the dome.

[0130] By using oculi of different optical designs, overlap of their FOVs can be created or avoided. Each of these approaches has its own advantages and disadvantages, and the final design will depend heavily on the real-time feedback logic that will be implemented.

[0131] By combining two types of optical designs (i.e., a narrow field-of-view photodiode group 220 directed to the treatment focal area and a wide field-of-view photodiode array 222) in a half-dome array of fast photodiodes (such as Fig.19 As shown in Figure 3, two types of information can be obtained: a focused spectral image from the actual treatment point and a spectral scattering distribution.

[0132] like Fig. 20 As shown, an initial possible implementation includes fast photodiodes with fast electronics as basic building blocks. Using current technology, sampling rates up to several GHz can be achieved, which is more than enough for this application. Spatially distributed acquisition can be addressed by building an array of sensors in the form of capturing the 3D angular distribution of scattered light (i.e., a half-dome pattern). In order to tile these sensors together, fiber-coupled sensors can be used. Fig. 20 The semi-dome configuration includes a geodesic dome 230 having a surface element that serves as the base for various functional ports: a treatment laser port 232, a fiber port 234 for a fast photoelectric sensor, an ommatidium port 236, and one or more illumination ports 238 that may also be fiber coupled. The array of sensor elements may be based on off-the-shelf components such as a Thorlabs DET025AFC fiber coupled silicon detector (2 GHz bandwidth, 150 ps rise time, 400 nm to 1100 nm). To achieve a good signal-to-noise ratio and enable multi-channel analysis, lock-in detection may be incorporated and the probe light source modulated. To perform multi-channel analysis simultaneously, multiple probe light sources may be used, each with a different modulation frequency. A simple lock-in amplifier for each sensor per channel may be implemented using, for example, an Analog-Devices AD630 balanced modulator / demodulator.

[0133] These sensors can be used for imaging using the compound eye concept described above. Some or all of the fiber ports can be engineered in a way that creates an artificial ommatidium. Such groups of ports on the same geo-dome surface element can be used and implemented on selected elements to ensure that the desired field of view is obtained.

[0134] Fig.21 Another dome arrangement is shown in . Fig.21 A dome structure 240 is shown with a large sensor array 242 and a small sensor array 244, a probing light source 246 which projects a light beam 248 which is reflected 243 at the skin surface to sensors in both the small and large arrays.

[0135] The proposed technology may well offer significant benefits over current commercial devices, as none appear to be addressing real-time monitoring of tissue properties at acquisition rates that would enable real-time feedback on the treatment process itself.

[0136] The skin diagnostic technology described in this article can be used as a platform for developing next-generation medical laser products and novel laser module technologies. Technology with real-time measurement of skin and target lesion properties may in the future inspire efforts to develop multi-wavelength laser technology that can switch wavelengths (and other laser properties) accordingly in real time. In addition, the skin diagnostic technology can be expanded to support and enhance the clinical diagnosis of lesions. For example, the skin diagnostic technology may be able to distinguish benign pigmented lesions from cancerous pigmented lesions. This may have a significant impact on patient management decisions. In addition, the developed skin diagnostic technology can serve as a novel and powerful research tool for developing new applications and lasers.

Claims

1. A device for treating skin tissue using a therapeutic light source, the device comprising: A handpiece, the handpiece comprising: a therapeutic light source along the optical axis; one or more illumination sources along or parallel to the optical axis, wherein the one or more illumination sources include one or more LED light sources; and one or more sensors configured to measure light reflected along or parallel to the optical axis; and A programmable controller, wherein the programmable controller is configured as follows: activating the one or more of the plurality of LED light sources according to a desired penetration depth into the skin tissue, the one or more LED light sources being directed toward the skin tissue, and illumination light from the one or more LED light sources being reflected from the skin tissue to an input of the one or more sensors; causing the one or more sensors to measure the light reflected from the skin tissue; receiving sensed information of measured light from outputs of the one or more sensors; processing the received sensed information of the measured light to determine the condition of the skin tissue; determining a therapeutic light regimen based on the determined condition of the skin tissue; and The therapeutic light source is activated according to the therapeutic light regimen to treat the skin tissue.

2. The device of claim 1, further comprising a light directing element that directs both the therapeutic light source and the one or more LED light sources along or parallel to the optical axis.

3. The device according to claim 1, wherein: The programmable controller is configured to select one or more wavelengths from the one or more LED light sources having different wavelengths and activate the one or more LED light sources to illuminate the skin tissue.

4. The device according to claim 1, wherein: The therapeutic light source is selected from one or more of the following: a fiber laser source, a solid-state laser source, an intense pulsed light source, and an LED light source.

5. The device according to claim 1, wherein: The skin tissue is treated for one or more of the following categories: pigmented lesions, blood vessel removal, tattoo removal, and hair removal.

6. The apparatus of claim 5, further comprising the programmable controller being configured to selectively activate the one LED light source or one or more of the plurality of LED light sources according to a skin tissue treatment category.

7. The apparatus according to claim 1, further comprising the programmable controller being configured to: After the step of treating the skin tissue, reactivating the one or more LED light sources to generate illumination light directed toward the skin tissue; causing the one or more sensors to measure the illumination light reflected from the skin tissue; receiving second sensed information of measured reflected light from the output of the one or more sensors; processing the sensed second information to determine a second condition of the skin tissue after treating the skin tissue; as well as A second therapeutic light plan is generated based on the second condition of the skin tissue.

8. The device according to claim 1, wherein: The programmable controller is configured to process the measured light received from the output end of the one or more sensors and provide a therapeutic light regimen by: analyzing the measured light, the sensed information, by matching it with information in a lookup table contained in a memory associated with the programmable controller; and selecting the therapeutic light regimen based on a match in the lookup table.

9. The device according to claim 1, wherein: The programmable controller is configured to process and analyze the measured light received from the output end of the one or more sensors by: matching the information of the received measured light with stored information contained in a memory associated with the programmable controller; and selecting the therapeutic light plan based on the match.

10. The device according to claim 1, wherein: The programmable controller is configured to process the measured light received from the output end of the one or more sensors and provide a therapeutic light regimen by: using artificial intelligence methods and deep learning to analyze the measured light, the sensed information, by matching it with information contained in a memory associated with the programmable controller; and selecting the therapeutic light regimen based on the match.